A detailed history of Russell Investments Group, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,739,939 shares of BMY stock, worth $92.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,739,939
Previous 2,934,296 40.7%
Holding current value
$92.5 Million
Previous $159 Million 54.59%
% of portfolio
0.12%
Previous 0.26%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $48.1 Million - $63.3 Million
-1,194,357 Reduced 40.7%
1,739,939 $72.3 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $33.7 Million - $38.2 Million
702,122 Added 31.45%
2,934,296 $159 Million
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $6.44 Million - $7.68 Million
132,813 Added 6.33%
2,232,174 $115 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $16.7 Million - $18.7 Million
-288,926 Reduced 12.1%
2,099,361 $122 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $6.69 Million - $7.43 Million
105,062 Added 4.6%
2,388,287 $153 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $18.7 Million - $21.2 Million
285,099 Added 14.27%
2,283,225 $158 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $6.41 Million - $7.59 Million
93,591 Added 4.91%
1,998,126 $144 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $13,646 - $8.07 Million
104,976 Added 5.83%
1,904,535 $136 Million
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $4.36 Million - $4.8 Million
60,015 Added 3.45%
1,799,559 $139 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $19.8 Million - $23.7 Million
-321,942 Reduced 15.62%
1,739,544 $127 Million
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $23.8 Million - $27.8 Million
443,873 Added 27.44%
2,061,486 $129 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $9.59 Million - $11.2 Million
-162,019 Reduced 9.1%
1,617,613 $96.1 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $991,055 - $1.08 Million
16,008 Added 0.91%
1,779,632 $119 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $22.3 Million - $25 Million
375,065 Added 27.01%
1,763,624 $111 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $2.56 Million - $2.9 Million
44,302 Added 3.3%
1,388,559 $86.1 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $16.7 Million - $18.5 Million
-290,046 Reduced 17.75%
1,344,257 $80.9 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $234,191 - $273,792
-4,272 Reduced 0.26%
1,634,303 $95.6 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $26.7 Million - $38.8 Million
-574,759 Reduced 25.97%
1,638,575 $90.6 Million
Q4 2019

Jan 29, 2020

SELL
$49.21 - $64.19 $9.21 Million - $12 Million
-187,123 Reduced 7.8%
2,213,334 $142 Million
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $5.2 Million - $6.16 Million
-121,481 Reduced 4.82%
2,400,457 $121 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $20.4 Million - $22.5 Million
-456,514 Reduced 15.33%
2,521,938 $114 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $14.9 Million - $17.8 Million
330,317 Added 12.47%
2,978,452 $142 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $36.5 Million - $47.3 Million
748,639 Added 39.41%
2,648,135 $137 Million
Q3 2018

Oct 26, 2018

BUY
$55.19 - $62.25 $19.2 Million - $21.6 Million
347,207 Added 22.37%
1,899,496 $118 Million
Q2 2018

Aug 08, 2018

SELL
$50.53 - $62.98 $19.2 Million - $23.9 Million
-379,736 Reduced 19.65%
1,552,289 $85.9 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $14.3 Million - $16.5 Million
239,319 Added 14.14%
1,932,025 $122 Million
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $4.56 Million - $4.98 Million
76,137 Added 4.71%
1,692,706 $105 Million
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $89.3 Million - $103 Million
1,616,569
1,616,569 $103 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.